Morgan Stanley lowers Accenture stock price target to $340 on macro concerns

Published 12/06/2025, 11:14
© Reuters

Morgan Stanley (NYSE:MS) reduced its price target on Accenture plc (NYSE:ACN) to $340.00 from $372.00 on Thursday, while maintaining an Equalweight rating on the global consulting firm’s stock. According to InvestingPro data, analyst targets for Accenture currently range from $280 to $395, with the stock trading at a P/E ratio of 26x.

The price target adjustment comes as Morgan Stanley notes that longer-duration deal conversions are helping to cushion Accenture against broader macroeconomic softness in the technology consulting sector.

The research firm expects management to raise the lower end of Accenture’s fiscal year 2025 growth guidance by 100 basis points to 6-7% year-over-year on a constant currency basis, compared to the previous guidance of 5-7% growth.

Morgan Stanley indicated that stable bookings are likely to keep the upper end of Accenture’s growth guidance unchanged, suggesting a mixed outlook for the company’s near-term performance.

The firm also highlighted potential vulnerabilities in Accenture’s Applied Intelligence and Software (ETR:SOWGn) (AFS) funding levels, noting that "DOGE pressure remains top of mind" as a continuing concern for the business segment.

In other recent news, Accenture has made significant strides with its AI Refinery platform in Europe, enhancing it with sovereign capabilities to ensure data control for organizations. This expansion, built on NVIDIA (NASDAQ:NVDA) Enterprise AI, aims to address data sovereignty concerns, particularly in critical sectors like energy and defense. Additionally, Accenture has invested in Reserv, an AI-driven insurance claims firm, to improve claims processing efficiency. This partnership is expected to streamline the claims process and enhance market competitiveness for insurers. In leadership changes, Ndidi Oteh has been appointed as the new CEO of Accenture Song, succeeding David Droga, who will assume a strategic vice chair role. Droga’s tenure saw Accenture Song’s revenue grow significantly, reflecting his impactful leadership. Meanwhile, TD Cowen has maintained its Buy rating on Accenture shares, with a price target of $336, despite industry growth concerns linked to Booz Allen (NYSE:BAH)’s financial results. Lastly, Accenture is partnering with OP Financial Group to modernize Pohjola Insurance’s IT systems, leveraging cloud technology and AI to enhance efficiency and customer service.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.